» Articles » PMID: 17492605

Isoniazid Activity is Terminated by Bacterial Persistence

Overview
Journal J Infect Dis
Date 2007 May 12
PMID 17492605
Citations 13
Authors
Affiliations
Soon will be listed here.
Citing Articles

Mycobacterial biofilms: A therapeutic target against bacterial persistence and generation of antibiotic resistance.

Sarangi A, Singh S, Das B, Rajput S, Fatima S, Bhattacharya D Heliyon. 2024; 10(11):e32003.

PMID: 38882302 PMC: 11176842. DOI: 10.1016/j.heliyon.2024.e32003.


Label-free affinity screening, design and synthesis of inhibitors targeting the Mycobacterium tuberculosis L-alanine dehydrogenase.

Kim H, Bacik J, Wu R, Jha R, Hebron M, Triandafillou C PLoS One. 2022; 17(11):e0277670.

PMID: 36395154 PMC: 9671377. DOI: 10.1371/journal.pone.0277670.


A model-informed preclinical approach for prediction of clinical pharmacodynamic interactions of anti-TB drug combinations.

Clewe O, Wicha S, de Vogel C, de Steenwinkel J, Simonsson U J Antimicrob Chemother. 2017; 73(2):437-447.

PMID: 29136155 PMC: 5890720. DOI: 10.1093/jac/dkx380.


Isoniazid Killing of Mycobacterium smegmatis NADH Pyrophosphatase Mutant at Single-Cell Level using Microfluidics and Time-Lapse Microscopy.

Elitas M Sci Rep. 2017; 7(1):10770.

PMID: 28883607 PMC: 5589797. DOI: 10.1038/s41598-017-11503-7.


Diverse drug-resistant subpopulations of Mycobacterium tuberculosis are sustained in continuous culture.

Ayabina D, Hendon-Dunn C, Bacon J, Colijn C J R Soc Interface. 2016; 13(124).

PMID: 27807274 PMC: 5134024. DOI: 10.1098/rsif.2016.0745.